Medicine recalls
|
|
The United States: Reumofan Plus: Recall - Undeclared Drug Ingredient |
|
FDA is warning consumers that Reumofan Plus, marketed as a natural dietary supplement for pain relief and other serious conditions, contains several active pharmaceutical ingredients not listed on the label that could be harmful.
An FDA laboratory analysis of Reumofan Plus found that it contains Diclofenac Sodium, a prescription non-steroidal anti-inflammatory drug (NSAID) that may cause increased risk of cardiovascular events such as heart attack and stroke, as well as serious gastrointestinal (GI) adverse events including bleeding, ulceration, and fatal perforation (causing a hole) of the stomach and intestines, and Methocarbamol, a prescription muscle relaxant that can cause sedation, dizziness, low blood pressure, and impair mental or physical abilities to perform tasks such as driving a motor vehicle or operating machinery.
The product is manufactured in Mexico by Riger Naturals. FDA has worked closely with the Mexican government on this matter. The Mexican Ministry of Health discovered that at least one lot of the product contains the corticosteroid dexamethasone, a drug that acts as an anti-inflammatory and immune system suppressant.
FDA has received multiple reports of adverse events associated with the use of Reumofan Plus, including liver injury, sudden worsening of glucose control, weight gain, swelling, leg cramps, and adrenal suppression. Consumers who are currently taking or who recently stopped taking Reumofan Plus are urged to consult a healthcare professional immediately.
Please refer to the following website in FDA for details:
http://www.fda.gov/Safety/MedWatch/../ucm306360.htm
In Hong Kong, the above product is a not a registered pharmaceutical product.
Ends/ Saturday, June 02, 2012
Issued at HKT 12:00 |
|
|